Amiodarone Hcl
Rank #344 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$29.9M
Total Cost
1,007,679
Total Claims
$29.9M
Total Cost
25,336
Prescribers
$30
Cost per Claim
263,515
Beneficiaries
1,979,079
30-Day Fills
$1,181
Avg Cost/Provider
40
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$29.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $29.9M total
Top Prescribers of Amiodarone Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Gary Reznik | Cardiology | Los Angeles, CA | 1,056 | $40K |
| 2 | Peter Chung | Cardiology | Los Angeles, CA | 225 | $32K |
| 3 | Henry Yee | Cardiology | Alhambra, CA | 606 | $25K |
| 4 | Lynne Hung | Clinical Cardiac Electrophysiology | Mission Viejo, CA | 595 | $23K |
| 5 | Atul Aggarwal | Cardiology | Bakersfield, CA | 273 | $22K |
| 6 | Jose Padilla | Cardiology | San Juan, PR | 190 | $22K |
| 7 | Don Lee | Interventional Cardiology | Glendale, CA | 358 | $21K |
| 8 | Antonio Cano | Cardiology | Doral, FL | 103 | $21K |
| 9 | Dipti Itchhaporia | Cardiology | Newport Beach, CA | 191 | $20K |
| 10 | Maninder Bedi | Cardiology | Weirton, WV | 950 | $19K |
| 11 | Leo Polosajian | Cardiology | Reseda, CA | 514 | $19K |
| 12 | Douglas Moore | Clinical Cardiac Electrophysiology | Roseville, MI | 171 | $18K |
| 13 | Bharath Reddy | Clinical Cardiac Electrophysiology | Brooklyn, NY | 336 | $18K |
| 14 | Deepak Kapadia | Cardiology | Madisonville, KY | 329 | $18K |
| 15 | Stephen Fahrig | Clinical Cardiac Electrophysiology | Nashville, TN | 872 | $18K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 341 | Testosterone (Testosterone) | $30.4M | 131,549 |
| 342 | Hydroxyzine Hcl (Hydroxyzine Hcl) | $30.2M | 1,474,936 |
| 343 | Irbesartan (Irbesartan) | $30.1M | 869,928 |
| 344 | Amiodarone Hcl (Amiodarone Hcl) | $29.9M | 1,007,679 |
| 345 | Esketamine Hcl (Spravato) | $29.0M | 20,816 |
| 346 | Warfarin Sodium (Warfarin Sodium) | $28.9M | 2,126,832 |
| 347 | Ivosidenib (Tibsovo) | $28.9M | 931 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology